Stock UniverseDerived research view · source repositories remain read-only

SAB Biotherapeutics, Inc. (SABS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.82
Global Rank
3126
Market Cap
195.19M
Latest Close
3.38
RS Composite
-22.81% · G#2781

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-11.05%
3M
-10.82%
6M
-8.65%
1Y
80.94%
3Y
-62.02%
5Y
-96.59%
10Y
-96.67%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 350.28K · 30-day average: 844.81K · Max drawdown over stored range: -99.01%

Research Snapshot

Relative Strength vs SPX

RS Composite-22.81%
20D RS-18.00%
60D RS-35.17%
120D RS-12.84%
Global RS Rank2781 · 17.11% percentile
Watch+Speculative RS Rank1702 · 18.84% percentile
Group ScopeWatch+Speculative
Primary RS Rank319 · 30.35% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank390 / 701
Primary Percentile44.51
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for SABS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue55.237860.876123.90422.2391.3224
Revenue Growth (YoY)1504.906%10.207%-60.733%-90.633%-40.937%
Gross Profit27.32913.6925-12.5343-14.276-28.9293
Operating Income20.5568-13.3932-28.9176-38.0753-42.9105
Free Cash Flow-2.7269-8.9568-25.6259-25.3166-34.6293-45.7083
Free Cash Flow Per Share-1.01-3.276-5.888-4.585-3.739-0.7451601432033316
EPS (Diluted) GAAP7.399999-6.299999-4.305759-7.641743-3.682316
EPS Growth
EPS Non-GAAP
Gross Margin49.475%6.066%-52.436%9800%9800%
Operating Margin37.215%-22.001%-120.973%-1700.557%-3244.873%
Profit Margin36.42%-28.163%-78.4%-1884.5%-2579.027%
Free Cash Flow Margin-4.937%-14.713%-107.203%-1130.713%-2618.649%
Shares Outstanding (Diluted)2.70112.73394.35255.52159.261961.3402
Shares Change (YoY)-23.298%1.213%59.204%26.858%67.743%562.284%

SEC Quarterly Fundamentals

No processed quarterly rows for SABS.